Vitalhub Corp.
TSX:VHI.TO · Toronto Stock Exchange
+$0.04 today
Vol 0.21M · Avg 0.41M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
2.3%
avg -29.8%
ROIC
4.2%
avg -12.8%
ROA
1.7%
avg -12.8%
Analysis
ROIC is currently the strongest return metric at 4.2% versus its period average of -12.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Daniel Matlow | President, Chief Executive Officer & Director | $725,500.00 | — | 64 | — | — |
Brian Leonard Goffenberg | Chief Financial Officer & Executive Vice President | $443,100.00 | — | 66 | — | — |
Mike Sanders | Executive Vice President of UK, Europe & Middle East | $403,437.00 | — | — | — | — |
Lisa Riley | Executive Vice President of Strategy and Growth | $374,859.00 | — | — | — | — |
Patrick Mazza | Chief Operating Officer | $368,500.00 | — | — | — | — |
Niels Tofting | Executive Vice President & MD of North American Operations | $245,000.00 | — | — | — | — |
Robert Lazar | Executive Vice President of Professional Services & Customer Care | $245,000.00 | — | — | — | — |
Vijit Coomara | Executive Vice President of Product Development | $218,000.00 | — | — | — | — |
Christian Sgro | Head of Investor Relations and Mergers & Acquisition Specialist | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +155.2% | +32.4% (10yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Recent growth has been strongest in Revenue at +155.2% over three years. Forward estimates point to Revenue at +32.4% (10yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Knight Therapeutics Inc.
TSX:GUD.TO
$922.89M
Bright Minds Biosciences Inc.
DRUG.CN
$663.07M
Kneat.com, Inc.
TSX:KSI.TO
$618.13M
Verano Holdings Corp.
VRNO.NE
$594.30M
Cresco Labs Inc.
CL.CN
$410.90M
Cipher Pharmaceuticals Inc.
TSX:CPH.TO
$408.55M
Spectral Medical Inc.
TSX:EDT.TO
$399.05M
High Tide Inc.
HITI.V
$289.97M
TerrAscend Corp.
TSX:TSND.TO
$284.80M
Aurora Cannabis Inc.
TSX:ACB.TO
$234.21M
Who manages VHI.TO?
Vitalhub Corp. (VHI.TO) lists 9 active executives. The top listed executive is Brian Leonard Goffenberg, Chief Financial Officer & Executive Vice President.
Explore More
Continue the stock analysis
Jump to another research area for this company.